Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy

19991,361 citationsJournal Articlebronze Open Access

Authors

Stephen R. Durham · Royal Brompton & Harefield NHS Foundation Trust

Samantha Walker · National Health Service

Eva‐Maria Varga · Lung Institute

Mikila R. Jacobson · Lung Institute

Fiona O’Brien · Lung Institute

Wendy Noble · Lung Institute

Stephen J. Till ·

Abstract

Immunotherapy for grass-pollen allergy for three to four years induces prolonged clinical remission accompanied by a persistent alteration in immunologic reactivity.

Topics & Keywords

Allergic Rhinitis and Sensitization Dermatology and Skin Diseases Asthma and respiratory diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 341, Issue 7, pp. 468-475

DOI: 10.1056/nejm199908123410702

Field-Weighted Citation Impact: 16.55